Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Peptide-based Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
J & J
AbbVie
Novo Nordisk
Eli Lilly
AstraZeneca
Teva
Ferring
Merck
Novartis
Sanofi
The Medicines
Takeda
Ipsen
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Injection
Oral
Other
Application:
Cancer
Metabolic Disorders
Central Nervous System
Other
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Peptide-based Drug Industry Overview
-
1.1.1 Peptide-based Drug Market Scope and Market Segments
-
1.1.2 Peptide-based Drug Industry Characteristics
-
1.1.3 Global and China Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Peptide-based Drug Production Value and Growth Rate (2017-2028)
-
1.2 Global Peptide-based Drug Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Injection
-
1.2.2 Oral
-
1.2.3 Other
-
1.3 Global Peptide-based Drug Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Cancer
-
1.3.2 Metabolic Disorders
-
1.3.3 Central Nervous System
-
1.3.4 Other
-
1.4 Market Analysis by Region
-
1.4.1 North America Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Peptide-based Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Peptide-based Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Peptide-based Drug Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Peptide-based Drug Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Peptide-based Drug Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Peptide-based Drug Industry Porter's Five Forces Model Analysis
-
2.2.3 Peptide-based Drug Industry PEST Analysis
-
2.3 Peptide-based Drug Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Peptide-based Drug Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Peptide-based Drug Industry
Chapter 3 Global and China Peptide-based Drug Market, by Manufacturer
-
3.1 Global and China Peptide-based Drug Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Peptide-based Drug Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Peptide-based Drug Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Peptide-based Drug Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Peptide-based Drug Market Top 3 Players
Chapter 4 Global and China Peptide-based Drug Market, by Type (2017-2028)
-
4.1 Peptide-based Drug Market Trend, by Type
-
4.2 Global Peptide-based Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Peptide-based Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Peptide-based Drug Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Peptide-based Drug Price Trend, by Type (2017-2028)
-
4.3 China Peptide-based Drug Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Peptide-based Drug Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Peptide-based Drug Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Peptide-based Drug Price Trend, by Type (2017-2028)
Chapter 5 Global and China Peptide-based Drug Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Peptide-based Drug Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Peptide-based Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Peptide-based Drug Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Peptide-based Drug Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Peptide-based Drug Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Peptide-based Drug Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Peptide-based Drug Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Peptide-based Drug Market Analysis
-
7.1 North America Peptide-based Drug Market, by Type
-
7.2 North America Peptide-based Drug Market, by Application
-
7.3 North America Peptide-based Drug Market Analysis and Forecast, by Country
-
7.3.1 United States Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Peptide-based Drug Market Analysis
-
8.1 Europe Peptide-based Drug Market, by Type
-
8.2 Europe Peptide-based Drug Market, by Application
-
8.3 Europe Peptide-based Drug Market Analysis and Forecast, by Country
-
8.3.1 Germany Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Peptide-based Drug Market Analysis
-
9.1 APAC Peptide-based Drug Market, by Type
-
9.2 APAC Peptide-based Drug Market, by Application
-
9.3 APAC Peptide-based Drug Market Analysis and Forecast, by Country
-
9.3.1 China Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Peptide-based Drug Market Analysis
-
10.1 Latin America, Middle East and Africa Peptide-based Drug Market, by Type
-
10.2 Latin America, Middle East and Africa Peptide-based Drug Market, by Application
-
10.3 Latin America, Middle East and Africa Peptide-based Drug Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Peptide-based Drug Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Peptide-based Drug Company Profiles
-
11.1 J & J
-
11.1.1 J & J Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 J & J Peptide-based Drug Product Profiles, Application and Specification
-
11.1.3 J & J Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 AbbVie
-
11.2.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 AbbVie Peptide-based Drug Product Profiles, Application and Specification
-
11.2.3 AbbVie Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Novo Nordisk
-
11.3.1 Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Novo Nordisk Peptide-based Drug Product Profiles, Application and Specification
-
11.3.3 Novo Nordisk Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Eli Lilly
-
11.4.1 Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Eli Lilly Peptide-based Drug Product Profiles, Application and Specification
-
11.4.3 Eli Lilly Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 AstraZeneca
-
11.5.1 AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 AstraZeneca Peptide-based Drug Product Profiles, Application and Specification
-
11.5.3 AstraZeneca Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Teva
-
11.6.1 Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Teva Peptide-based Drug Product Profiles, Application and Specification
-
11.6.3 Teva Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Ferring
-
11.7.1 Ferring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Ferring Peptide-based Drug Product Profiles, Application and Specification
-
11.7.3 Ferring Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Merck
-
11.8.1 Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Merck Peptide-based Drug Product Profiles, Application and Specification
-
11.8.3 Merck Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 Novartis
-
11.9.1 Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 Novartis Peptide-based Drug Product Profiles, Application and Specification
-
11.9.3 Novartis Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.10 Sanofi
-
11.10.1 Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.10.2 Sanofi Peptide-based Drug Product Profiles, Application and Specification
-
11.10.3 Sanofi Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.11 The Medicines
-
11.11.1 The Medicines Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.11.2 The Medicines Peptide-based Drug Product Profiles, Application and Specification
-
11.11.3 The Medicines Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.12 Takeda
-
11.12.1 Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.12.2 Takeda Peptide-based Drug Product Profiles, Application and Specification
-
11.12.3 Takeda Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.13 Ipsen
-
11.13.1 Ipsen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.13.2 Ipsen Peptide-based Drug Product Profiles, Application and Specification
-
11.13.3 Ipsen Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Peptide-based Drug Industry Investment Prospect and Risk Assessment
-
12.1 Peptide-based Drug Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Peptide-based Drug Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Global Peptide-based Drug Production Value and Growth Rate (2017-2028)
-
Figure China Peptide-based Drug Production Value and Growth Rate (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Oral (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Other (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Cancer (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Metabolic Disorders (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Central Nervous System (2017-2028)
-
Figure Global Peptide-based Drug Market Size and Growth Rate of Other (2017-2028)
-
Figure North America Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Peptide-based Drug Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Peptide-based Drug Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Peptide-based Drug Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Peptide-based Drug Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Peptide-based Drug Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Peptide-based Drug Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Peptide-based Drug Market Share, by Manufacturer in 2021
-
Figure Global and China Peptide-based Drug Market Share, by Manufacturer in 2022
-
Table Global Peptide-based Drug Sales Volume, by Type (2017-2028)
-
Table Global Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure Global Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Table Global Peptide-based Drug Sales Value, by Type (2017-2028)
-
Table Global Peptide-based Drug Sales Value Share, by Type (2017-2028)
-
Figure Global Peptide-based Drug Price Trend, by Type (2017-2028)
-
Table China Peptide-based Drug Sales Volume, by Type (2017-2028)
-
Table China Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure China Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Table China Peptide-based Drug Sales Value, by Type (2017-2028)
-
Table China Peptide-based Drug Sales Value Share, by Type (2017-2028)
-
Figure China Peptide-based Drug Price Trend, by Type (2017-2028)
-
Table Global Peptide-based Drug Sales Volume, by Application (2017-2028)
-
Table Global Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Global Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Table Global Peptide-based Drug Sales Value, by Application (2017-2028)
-
Table Global Peptide-based Drug Sales Value Share, by Application (2017-2028)
-
Figure Global Peptide-based Drug Sales Value Share, by Application (2017-2028)
-
Table China Peptide-based Drug Sales Volume, by Application (2017-2028)
-
Table China Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Table China Peptide-based Drug Sales Value, by Application (2017-2028)
-
Table China Peptide-based Drug Sales Value Share, by Application (2017-2028)
-
Figure China Peptide-based Drug Sales Value Share, by Application (2017-2028)
-
Figure China Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure North America Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Peptide-based Drug Production, Import, Consumption and Export (2017-2022)
-
Table North America Peptide-based Drug Sales Volume, by Type (2017-2028)
-
Table North America Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure North America Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Table North America Peptide-based Drug Sales Volume, by Application (2017-2028)
-
Table North America Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure North America Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure United States Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure United States Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Canada Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Table Europe Peptide-based Drug Sales Volume, by Type (2017-2028)
-
Table Europe Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure Europe Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Table Europe Peptide-based Drug Sales Volume, by Application (2017-2028)
-
Table Europe Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Europe Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Germany Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure UK Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure UK Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure France Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure France Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Italy Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Spain Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Poland Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Russia Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Table APAC Peptide-based Drug Sales Volume, by Type (2017-2028)
-
Table APAC Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure APAC Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Table APAC Peptide-based Drug Sales Volume, by Application (2017-2028)
-
Table APAC Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure APAC Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure China Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure China Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Japan Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure India Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure India Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Peptide-based Drug Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Peptide-based Drug Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Peptide-based Drug Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Peptide-based Drug Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Peptide-based Drug Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Peptide-based Drug Sales Value and Growth Rate (2017-2028)
-
Table J & J Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table J & J Product Profiles, Application and Specification
-
Table J & J Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AbbVie Product Profiles, Application and Specification
-
Table AbbVie Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novo Nordisk Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novo Nordisk Product Profiles, Application and Specification
-
Table Novo Nordisk Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Eli Lilly Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Eli Lilly Product Profiles, Application and Specification
-
Table Eli Lilly Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table AstraZeneca Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table AstraZeneca Product Profiles, Application and Specification
-
Table AstraZeneca Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Teva Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Teva Product Profiles, Application and Specification
-
Table Teva Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ferring Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ferring Product Profiles, Application and Specification
-
Table Ferring Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Merck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Merck Product Profiles, Application and Specification
-
Table Merck Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Novartis Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Novartis Product Profiles, Application and Specification
-
Table Novartis Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Sanofi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Sanofi Product Profiles, Application and Specification
-
Table Sanofi Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table The Medicines Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table The Medicines Product Profiles, Application and Specification
-
Table The Medicines Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Takeda Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Takeda Product Profiles, Application and Specification
-
Table Takeda Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Ipsen Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Ipsen Product Profiles, Application and Specification
-
Table Ipsen Peptide-based Drug Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
